COM:CARDIOLRX
Cardiol Therapeutics Inc.
- Stock
Last Close
2.22
22/11 21:00
Market Cap
189.75M
Beta: -
Volume Today
109.83K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -1.66M - | -15.89M 856.92% | -13.68M 13.90% | -20.64M 50.84% | -31.64M 53.28% | -30.93M 2.24% | -28.13M 9.06% | |
depreciation and amortization | 53.34K - | 91.49K 71.52% | 150.57K 64.57% | 229.54K 52.44% | 220.42K 3.97% | 219.91K 0.23% | 248.35K 12.94% | |
deferred income tax | 7.88M - | -4.92M - | ||||||
stock based compensation | 1.65M - | 3.27M 97.57% | 2.77M 15.35% | 8.50M 207.33% | 5.01M 41.01% | |||
change in working capital | 48.38K - | -5.20M 10,851.54% | -1.62M 68.85% | 8.32M 613.12% | 76.52K 99.08% | 5.75M 7,411.68% | -545.88K 109.50% | |
accounts receivables | -467.09K - | 707.95K 251.57% | -59.95K 108.47% | -144.18K 140.52% | 200.32K 238.94% | |||
inventory | 142.58K - | 1.10M 672.05% | 17.97K 98.37% | -4.47M 25,004.31% | ||||
accounts payables | 176.71K - | 1.96M 1,011.79% | 467.09K 76.23% | -707.95K 251.57% | 2.39M 438.03% | 4.47M 86.99% | -1.29M 128.89% | |
other working capital | -128.33K - | -7.17M 5,484.72% | -1.76M 75.40% | 7.22M 509.20% | -2.27M 131.53% | 5.89M 359.04% | 546.47K 90.73% | |
other non cash items | 267.01K - | 574.86K 115.30% | 507.74K 11.68% | 144.99K 71.44% | 4.21M 2,802.96% | -7.27M 272.74% | 3.25M 144.64% | |
net cash provided by operating activities | -1.29M - | -10.89M 743.06% | -11.38M 4.46% | -9.19M 19.29% | -23.55M 156.39% | -27.22M 15.58% | -25.18M 7.49% | |
investments in property plant and equipment | -29.17K - | -13.79K 52.72% | -424.31K 2,976.68% | -40.60K 90.43% | -12.92K 68.19% | -74.71K 478.42% | -64.31K 13.92% | |
acquisitions net | ||||||||
purchases of investments | ||||||||
sales maturities of investments | ||||||||
other investing activites | ||||||||
net cash used for investing activites | -29.17K - | -13.79K 52.72% | -424.31K 2,976.68% | -40.60K 90.43% | -12.92K 68.19% | -74.71K 478.42% | -64.31K 13.92% | |
debt repayment | -20.19K - | -50.47K 150.00% | -51.92K 2.86% | -53.93K 3.89% | ||||
common stock issued | 3.40M - | 14.23M 318.83% | 1.67M 88.29% | 17.25M 934.71% | 84.08M 387.44% | |||
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | 279.45K - | 11.05M 3,853.85% | 382.15K 96.54% | -904.51K 336.69% | 9.41M 1,139.87% | |||
net cash used provided by financing activities | 3.68M - | 25.28M 587.43% | 2.03M 91.97% | 16.30M 703.07% | 93.44M 473.41% | -53.93K 100.06% | -55.38K 2.67% | |
effect of forex changes on cash | -56.03K - | -11.13K 80.14% | 2.92M 26,335.83% | 762.04K 73.90% | ||||
net change in cash | 2.36M - | 14.37M 510.01% | -9.78M 168.00% | 7.07M 172.31% | 69.87M 888.46% | -24.43M 134.96% | -24.54M 0.45% | |
cash at beginning of period | 2.36M - | 16.73M 610.01% | 6.96M 58.42% | 14.03M 101.62% | 83.90M 498.20% | 59.41M 29.19% | ||
cash at end of period | 2.36M - | 16.73M 610.01% | 6.96M 58.42% | 14.03M 101.62% | 83.90M 498.20% | 59.47M 29.12% | 34.87M 41.37% | |
operating cash flow | -1.29M - | -10.89M 743.06% | -11.38M 4.46% | -9.19M 19.29% | -23.55M 156.39% | -27.22M 15.58% | -25.18M 7.49% | |
capital expenditure | -29.17K - | -13.79K 52.72% | -424.31K 2,976.68% | -40.60K 90.43% | -12.92K 68.19% | -74.71K 478.42% | -64.31K 13.92% | |
free cash flow | -1.32M - | -10.91M 725.49% | -11.80M 8.22% | -9.23M 21.84% | -23.56M 155.40% | -27.30M 15.84% | -25.24M 7.51% |
All numbers in CAD (except ratios and percentages)